{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:08:52Z","timestamp":1779170932899,"version":"3.51.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is a hematologic malignancy characterized by heterogeneity, poor prognosis, and limited biomarkers for risk prediction. Mitochondria pathway related genes (MPRGs), as central regulators of cellular metabolism and immune microenvironment dynamics, may provide useful information for prognostic assessment and biological characterization in AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      MPRGs were obtained from the MitoCarta3.0 database. Univariate Cox and Kaplan-Meier methods were conducted to analyze their prognostic relevance. LASSO penalized regression followed by stepwise multivariate Cox analysis yielded an optimal gene panel in the TCGA-LAML dataset. External validation was performed across three GEO datasets (GSE10358, GSE106291, GSE71014). Finally, the role of UCP2 was examined\n                      <jats:italic>in vitro<\/jats:italic>\n                      by assessing UCP2 knockdown effects on MOLM-13 cell behavior.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A prognostic signature comprising seven MPRGs (UCP2, FAM162A, ACCS, HSD1, ACSF2, PPIF, and SDHA) was established. High-risk patients exhibited significantly shorter survival. The MPRGs risk score served as an independent predictor of prognosis. Moreover, elevated risk scores correlated with heightened immune checkpoint molecule expression and an immunosuppressive tumor microenvironment. UCP2 knockdown attenuated both proliferative capacity and migratory potential in MOLM-13 AML cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, the MPRG-based signature provides independent prognostic value in AML and reflects its association with an immunosuppressive microenvironment. These findings provide additional evidence that mitochondrial pathway-related genes are associated with AML prognosis and immune microenvironment features. UCP2 may represent a biologically relevant candidate gene in AML, although further mechanistic and clinical validation is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1765805","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:40:58Z","timestamp":1779169258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and experimental validation of mitochondria pathway related genes in acute myeloid leukemia"],"prefix":"10.3389","volume":"17","author":[{"given":"Rui","family":"Dou","sequence":"first","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunmin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Henan Key Laboratory of Stem Cell Differentiation and Modification, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Department of Hematology, Henan Provincial People\u2019s Hospital, Zhengzhou University People\u2019s Hospital, Henan University People\u2019s Hospital","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01099-7","article-title":"The global epidemiology of acute myeloid leukemia","volume":"23","author":"El Chaer","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","article-title":"NCCN guidelines insights: acute myeloid leukemia, version 2.2021","volume":"19","author":"Pollyea","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukemia","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and cancer","volume":"61","author":"Zong","year":"2016","journal-title":"Mol Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5575","article-title":"Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma","volume":"8","author":"Sharma","year":"2022","journal-title":"Sci Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028933","article-title":"Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation","volume":"147","author":"Ling","year":"2025","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3659","article-title":"Loss of SETD8 impairs mitochondrial homeostasis to suppress leukemia stem cell function in t(8;21) acute myeloid leukemia","volume":"85","author":"Su","year":"2025","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-020-03156-8","article-title":"SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism","volume":"11","author":"Polak","year":"2020","journal-title":"Cell Death Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.10.001","article-title":"Extinguishing the embers: targeting AML metabolism","volume":"27","author":"Culp-Hill","year":"2021","journal-title":"Trends Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2025.10.004","article-title":"Mitochondrial transfer at the crossroads of cancer, stromal, and immune cells","volume":"15","author":"Ishino","year":"2025","journal-title":"Trends Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70192","article-title":"From mitochondria to immunity: the emerging roles of mitochondria-derived vesicles and small extracellular vesicles in cellular communication and disease","volume":"14","author":"Horbay","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216223","article-title":"Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria","volume":"564","author":"Bai","year":"2023","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12943-024-02175-9","article-title":"Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells","volume":"23","author":"Yang","year":"2024","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1432633","article-title":"Targeting mitochondrial damage: shining a new light on immunotherapy","volume":"15","author":"Zeng","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597633","article-title":"Integrated bioinformatic analysis and machine learning developed a prognostic model based on mitochondrial function for acute myeloid leukemia","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","article-title":"TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data","volume":"24","author":"Liao","year":"2023","journal-title":"BMC Bioinf"},{"key":"B19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100910","article-title":"Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0","volume":"4","author":"Zeng","year":"2024","journal-title":"Cell Rep Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-025-01585-8","article-title":"Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T\/myeloid mixed-phenotype acute leukemia","volume":"18","author":"Huang","year":"2025","journal-title":"Genome Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025030816","article-title":"Azacitidine to treat measurable residual disease in patients with MDS\/AML: final long-term results of the RELAZA2 trial","volume":"147","author":"Platzbecker","year":"2025","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41746-025-02185-x","article-title":"Machine learning-driven glycolytic subtyping and exosome-based PKM splicing modulation overcome drug resistance in hyper-glycolytic myeloid leukemia","volume":"9","author":"Zhong","year":"2025","journal-title":"NPJ Digit Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1407-0","article-title":"UCP2, a mitochondrial protein regulated at multiple levels","volume":"71","author":"Donadelli","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030714","article-title":"UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions","volume":"7","author":"Deng","year":"2012","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3390\/ijms26094102","article-title":"Epicatechin decreases UCP2 gene expression in MDA-MB-231 breast cancer cells by the presence of a regulatory element in the promoter","volume":"26","author":"Pereyra-Vergara","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13048-025-01664-9","article-title":"Molecular characteristics of early- and late-onset ovarian cancer: insights from multidimensional evidence","volume":"18","author":"Shen","year":"2025","journal-title":"J Ovarian Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2019.04.013","article-title":"Regulation of succinate dehydrogenase and role of succinate in cancer","volume":"98","author":"Dalla Pozza","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06156-x","article-title":"ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes","volume":"67","author":"Chen","year":"2024","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1186\/s12967-025-07267-8","article-title":"PPIF(+) neutrophils promote mtROS driven NETosis mediated progression of colorectal cancer","volume":"23","author":"Ying","year":"2025","journal-title":"J Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumor immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.257","article-title":"Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications","volume":"29","author":"Sportoletti","year":"2015","journal-title":"Leukemia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1765805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:41:01Z","timestamp":1779169261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1765805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1765805"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1765805","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1765805"}}